Expand this Topic clickable element to expand a topic
Skip to content
Optica Publishing Group
Conferences > ECBO > 2013 > NAII > 880008
  • Opto-Acoustic Methods and Applications
  • SPIE Proceedings (Optica Publishing Group, 2013),
  • paper 880008

Photoacoustic tomography assessment of vascular targeted therapy to determine vessel regrowth following treatment

S. P. Johnson, O. Ogunlade, E. Zhang, J. Laufer, V. Rajkumar, S. Walker-Samuel, M. F. Lythgoe, R. B. Pedley, and P. Beard P

Not Accessible

Your library or personal account may give you access

Abstract

Photoacoustic tomography (PAT) is ideally suited to image tissue vasculature and is therefore able to provide functional response data for the pharmacodynamic time course of vascular targeted therapies. We show in a preclinical model of colorectal carcinoma that 40mg/kg of the vascular disrupting agent OXi4503 causes central tumour blood vessel destruction that can be assessed by PAT at 48 hours. This is confirmed with histological haematoxylin and eosin staining. Outward growth of solid tumours is then static until 16 days post-dose whilst vessel regrowth occurs inwardly to repopulate the necrotic core.

© 2013 SPIE

PDF Article
More Like This
In-vivo longitudinal photoacoustic tomography of the response of colorectal cancer models to vascular targeted therapy

O Ogunlade, SP Johnson, E Zhang, V Rajkumar, RB Pedley, and P Beard
JW4A.5 Cancer Imaging and Therapy (Cancer) 2016

In vivo preclinical photoacoustic imaging using all-optical detection and time-reversal image reconstruction

Jan Laufer, Peter Johnson, Edward Zhang, Bradley Treeby, Ben Cox, Barbara Pedley, and Paul Beard
BM2B.3 Biomedical Optics (BIOMED) 2012

In vivo preclinical photoacoustic imaging of cancer

Paul Beard
MTh2C.1 Optical Molecular Probes, Imaging and Drug Delivery (OMP) 2013

View More...
Select as filters
Select Topics Cancel
Top
       
© Copyright 2024 | Optica Publishing Group. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
Privacy | Terms of Use